RecruitingNot applicableEN originalLymphomaOther cancers

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Higher gut microbiome diversity has been associated with improved survival following autologous stem cell transplantation in multiple myeloma and lymphoma. This study hypothesises that prebiotic supplementation with resistant starch (RS) will improve gut microbiome diversity at time of stem cell engraftment. To test this, participants will either have RS or a placebo (maltodextrin) mixed into a food item of their choice for approximately 10 days prior to stem cell infusion and continue to the first day of neutrophil engraftment. The study will look at the difference in gut microbiome diversity between the RS and placebo arm collected at the engraftment timepoint, dietary evaluation to assess the impact of subject diet on microbiome response to intervention and serum sample collection to assess differences to gut permeability during transplant.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Chętny do udziału w badaniu i podpisania zgody
  • Gotowy do wykonania wszystkich procedur badania
  • Potwierdzony nowotwór: szpiczak plazmocytowy, chłoniak nieziarniczy lub chłoniak Hodgkina
  • Zakwalifikowany do przeszczepu komórek macierzystych
  • Wiek co najmniej 19 lat
  • Pierwsza procedura przeszczepu komórek macierzystych

✗ Disqualifies

  • Historia operacji zmniejszającej żołądek
  • Chroniczna choroba przewodu pokarmowego lub zaburzenia absorpcji
  • Wcześniejsze problemy ze strawności rozpuszczalnego włókna
  • Alergia na skrobię ziemniaczaną lub maltodekstrynę
  • Niechętny do zbierania próbek stolca

Simplified criteria — AI translation

Trial details

Minimum age
19 Years
Last updated (source)
July 27, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Unversity of Nebraska Medical Center

Omaha, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/28/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.